Multidisciplinary consensus statement on the clinical management of patients with pancreatic cancer.
Elena Martín-PérezJ E Domínguez-MuñozF Botella-RomeroL CerezoF Matute TeresaT SerranoR VeraPublished in: Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico (2020)
Pancreatic cancer (PC) remains one of the most aggressive tumors with an increasing incidence rate and reduced survival. Although surgical resection is the only potentially curative treatment for PC, only 15-20% of patients are resectable at diagnosis. To select the most appropriate treatment and thus improve outcomes, the diagnostic and therapeutic strategy for each patient with PC should be discussed within a multidisciplinary expert team. Clinical decision-making should be evidence-based, considering the staging of the tumor, the performance status and preferences of the patient. The aim of this guideline is to provide practical and evidence-based recommendations for the management of PC.
Keyphrases
- decision making
- end stage renal disease
- case report
- chronic kidney disease
- quality improvement
- newly diagnosed
- palliative care
- ejection fraction
- squamous cell carcinoma
- lymph node
- clinical practice
- peritoneal dialysis
- adipose tissue
- radiation therapy
- rectal cancer
- pet ct
- locally advanced
- skeletal muscle
- glycemic control
- patient reported outcomes
- smoking cessation